FinVector Oy

FinVector is a fast-growing and internationally renowned biopharmaceutical company that develops and manufactures viral-based gene therapy products. As a pioneer in its operational field, FinVector has extensive experience of nearly 30 years in cGMP manufacturing. The company’s operations are centred in Kuopio, Finland. As a truly international workplace, FinVector employs hundreds of professionals that represent numerous nationalities. FinVector works on cutting-edge biopharmaceuticals and has invested in building state-of-the-art development and GMP facilities for Viral Vector and Cell Therapy platforms including vaccines. FinVector is owned by Ferring Ventures, a subsidiary of Ferring Foundation B.V. Learn more: www.finvector.com Instagram: @we_are_finvector - https://www.instagram.com/we_are_finvector/ LinkedIn: FinVector Oy - https://www.linkedin.com/company/finvector/